TRRI OTC
Alzex Neuropharma Inc.
1W: +0.0%
1M: +0.0%
3M: -66.7%
YTD: +100.0%
1Y: -99.4%
3Y: -99.7%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-0M
Net Income
-107.0% YoY
$-0M
Free Cash Flow
+66.8% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE87.5%
ROA-5486.4%
ROIC59.3%
Valuation
P/E-0.0
P/B-0.0
EV/EBITDA-2.2
Leverage
Debt/Equity-0.26
Current Ratio0.02
Interest Cov.-31.4x
Quality Scores
Piotroski F4/9
Altman Z-449.22
Beneish M0.00